Quality of care in patients with type 1 diabetes during the COVID-19 pandemic: a cohort study from Southern Brazil

Table 1 Baseline demographic and clinical characteristics of the included participants (n = 289)

Patient characteristic	Female n = 143	Male n = 146	p-value^a
Age (years)	38 (30–50)	39 (32–50)	0.340
Diabetes duration (years)	21 (14–30)	25 (15–31)	0.271
BMI (kg/m²)	24.8 (22.5–27.3)	24.8 (22.7–27.9)	0.680
Blood pressure (mmHg)
Systolic	120 (110–130)	120 (115–138)	0.014
Diastolic	70 (70–80)	80 (70–80)	0.018
Chronic complications of diabetes n (%)
Retinopathy	68 (47.6)	78 (53.4)	0.379
Nephropathy	24 (16.9)	27 (18.6)	0.821
Neuropathy	21 (14.8)	29 (20.1)	0.300
Limb amputation	2 (1.4)	6 (4.1)	0.296
Foot injuries	6 (4.2)	18 (12.3)	0.022
Macrovascular complications	12 (8.4)	13 (8.9)	1.000
Smoker n (%)	12 (8.4)	15 (10.3)	0.714
Dyslipidemia	19 (13.5)	21 (14.6)	0.921
Psychiatric disease	52 (37.1)	17 (12.3)	< 0.001
Arterial hypertension	37(25.9)	50 (34.2)	0.155

Data presented as number (%) for categorical variables or median and interquartile range for continuous variables
^aThe p-value is given for the Yates’s correction for continuity test for categorical variables and the Mann–Whitney U test for continuous variables. BMI: body mass index. Macrovascular complications included stroke, ischemic heart disease and peripheral arterial disease

ISSN: 1758-5996